ClinicalTrials.Veeva

Menu

Biobeat Digital Home Monitoring Feasibility

L

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

Status

Enrolling

Conditions

Home Monitoring
Thoracic Surgery

Treatments

Other: Digital Group

Study type

Interventional

Funder types

Other

Identifiers

NCT06417996
Digital Home Monitoring

Details and patient eligibility

About

To assess the feasibility of evaluating postoperative home monitoring with Biobeat digital monitoring. The investigators hypothesize that the Biobeat digital home monitoring platform will lead to a decrease in unplanned visits to the ED (Emergency Department). In addition, patients' quality of life is postulated to be improved compared to patients receiving the current standard of care without home monitoring.

Full description

This trial will be a single centre, parallel arm, randomized controlled feasibility trial. The investigators will evaluate postoperative home monitoring with the Biobeat digital monitoring and two-way communication through the digital portal for 4 weeks post-operatively to the standard of care (no digital monitoring) in thoracic surgery patients undergoing elective thoracic surgical procedures. The investigators will assess whether conducting a larger randomized trial of digital home monitoring vs. standard of care is feasible in terms of recruitment, data collection and logistics.

Enrollment

48 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patient willing to provide informed consent
  • Wi-fi or cellular connectivity at the patient's home
  • Patient undergoing elective lung cancer surgery
  • Patient familiar/comfortable with the use of technology such as online banking.

Exclusion criteria

  • Patients who are not comfortable with the use of technology.

Trial design

Primary purpose

Health Services Research

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

48 participants in 2 patient groups

Control Group
No Intervention group
Description:
The control group will not be monitored with continuity of care.
Digital Group
Experimental group
Description:
At the time of hospital discharge, the control group will be discharged without receipt of home monitoring, and the intervention group will receive a home monitoring kit with (NIBP (non-invasive blood pressure) and SPO2 (pulse oximetry) with instructions on how to use these devices. Patients in the intervention groups will receive digital communication for four weeks and have their NIBP, HR (heart rate), SPO2 and pain scores evaluated twice a day for two weeks.
Treatment:
Other: Digital Group

Trial contacts and locations

1

Loading...

Central trial contact

Deb Lewis

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems